- home
- about us
- Investment Approach
- Client Service Approach
- Market Analysis Summary
- Mission Statement
- Value Proposition
- Team Biographies
- Firm ADV PDFs
- Form CRS
- Firm Brochure-Part 2A of Form ADV
- Brochure Supplement Amit Stavinsky
- Brochure Supplement Frank Parks
- Brochure Supplement Dominick Savo
- Brochure Supplement Richard Mason
- Brochure Supplement Joe Estes
- Brochure Supplement Jonathan Ezra
- Statement Of Financial Strength
- Job Opportunities
- Letter to Clients
- member log-in
- contact us
Latest News about ALT
Recent news which mentions ALT
From Benzinga
From Benzinga
Should Pfizer Acquire Viking Therapeutics to Take on Eli Lilly and Novo Nordisk in the Obesity Drug Market?
March 15, 2024
From Motley Fool
From Benzinga
Why Helix Energy Solutions Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
February 27, 2024
From Benzinga
Why Freshpet Shares Are Trading Higher By Around 15%? Here Are Other Stocks Moving In Monday's Mid-Day Session
February 26, 2024
From Benzinga
Altimmune Stock Surges, Kerrisdale Remains Short: What You Need To Know
February 26, 2024
From Benzinga
TEVA Stock Pops 4% as Teva Receives FDA Approval
February 26, 2024
From InvestorPlace
Why Is Altimmune (ALT) Stock Up 14% Today?
February 26, 2024
From InvestorPlace
12 Health Care Stocks Moving In Monday's Pre-Market Session
February 26, 2024
From Benzinga
3 Biotech Stocks to Turn $10,000 Into $1 Million: February 2024
February 22, 2024
From InvestorPlace
Kerrisdale Capital Slams Altimmune (ALT) Stock in New Short Report
February 13, 2024
From InvestorPlace
Altimmune Stock Sinks As Kerrisdale Capital Announces Short Position: 'Obvious Dead End'
February 13, 2024
From Benzinga
Why IPG Photonics Shares Are Trading Lower By Around 11%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
February 13, 2024
From Benzinga
Jim Cramer Calls Affirm 'A Winner,' But Not C3.ai: 'I Can't Recommend A Stock With No Earnings'
February 13, 2024
From Benzinga
Stocks to Watch: 3 Companies Working on Next-Gen Weight Loss Drugs
January 25, 2024
From InvestorPlace
Large Drugmakers Show Enthusiasm To Embrace $100B Obesity Market, Despite Novo And Lilly's Dominance
January 11, 2024
From Benzinga
The 3 Best Biotech Stocks to Buy in January 2024
January 09, 2024
From InvestorPlace
Harpoon Therapeutics, Heron Therapeutics And Other Big Stocks Moving Higher In Monday's Pre-Market Session
January 08, 2024
From Benzinga
What's Going On With Obesity Drug-Developer Altimmune Inc Stock?
January 04, 2024
From Benzinga
Coherus BioSciences And Other Big Stocks Moving Higher In Wednesday's Pre-Market Session
December 27, 2023
From Benzinga
Gracell Biotechnologies, Stratasys, Hollysys Automation Technologies And Other Big Stocks Moving Higher In Tuesday's Pre-Market Session
December 26, 2023
From Benzinga
Russell 2000 Rallies To 16-Month Highs: Best Performing Small-Cap Stocks Popping Over 80% In December
December 19, 2023
From Benzinga
Bernie Sanders To Take On Ozempic, Wegovy, Weight Loss Drugs: 'Could Be Helpful, But They're Not Going To Be Helpful If People Can't Afford Them'
December 08, 2023
From Benzinga
Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Secretly Monitor But Don't Talk About Yet
December 08, 2023
From Benzinga
$1000 Invested In Altimmune 5 Years Ago Would Be Worth This Much Today
December 08, 2023
Tickers
ALT
From Benzinga
Why Methode Electronics Shares Are Trading Lower By Over 14%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
December 07, 2023
From Benzinga
From MarketWatch
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.